On Friday, Tempus AI received a positive adjustment to its Relative Strength (RS) Rating, from 78 to 88.
Looking For The Best Stocks To Buy And Watch? Start Here
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners typically have an RS Rating north of 80 in the early stages of their moves.
Tempus AI has climbed more than 5% past a 74.83 entry in a first-stage cup without handle, meaning it's now out of a proper buy range. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Tempus AI reported 0% EPS growth in its most recent report, while sales growth came in at 90%.
The company earns the No. 3 rank among its peers in the Medical-Research Equipment/Services industry group. Medpace Holdings is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
